29 related articles for article (PubMed ID: 23034938)
1. CHILKBP protects against podocyte injury by preserving ZO-1 expression.
Guo C; Ding Y; Yang A; Geng Y; Liu C; Zhou L; Ma L; Yang Z; Hu F; Jiang K; Cai R; Bai P; Quan M; Deng Y; Wu C; Sun Y
Cell Mol Life Sci; 2022 Dec; 80(1):18. PubMed ID: 36564652
[TBL] [Abstract][Full Text] [Related]
2. High glucose induces podocyte injury via enhanced (pro)renin receptor-Wnt-β-catenin-snail signaling pathway.
Li C; Siragy HM
PLoS One; 2014; 9(2):e89233. PubMed ID: 24533170
[TBL] [Abstract][Full Text] [Related]
3. Triptolide decreases podocytes permeability by regulating TET2-mediated hydroxymethylation of ZO-1.
Tang YW; Jiang MY; Cao JW; Wan F
Exp Biol Med (Maywood); 2024; 249():10051. PubMed ID: 38881848
[TBL] [Abstract][Full Text] [Related]
4. Activation of Wnt/β-Catenin Signaling Involves 660 nm Laser Radiation on Epithelium and Modulates Lipid Metabolism.
Xiao Q; Wang L; Zhang J; Zhong X; Guo Z; Yu J; Ma Y; Wu H
Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291598
[TBL] [Abstract][Full Text] [Related]
5. TAZ is important for maintenance of the integrity of podocytes.
Chen J; Wang X; He Q; Harris RC
Am J Physiol Renal Physiol; 2022 Apr; 322(4):F419-F428. PubMed ID: 35157550
[TBL] [Abstract][Full Text] [Related]
6.
Hernández-Guzmán C; Gallego-Gutiérrez H; Chávez-Munguía B; Martín-Tapia D; González-Mariscal L
Cells; 2021 Sep; 10(10):. PubMed ID: 34685547
[TBL] [Abstract][Full Text] [Related]
7. ZO-2 Is a Master Regulator of Gene Expression, Cell Proliferation, Cytoarchitecture, and Cell Size.
González-Mariscal L; Gallego-Gutiérrez H; González-González L; Hernández-Guzmán C
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450555
[TBL] [Abstract][Full Text] [Related]
8. The SGK3-triggered ubiquitin-proteasome degradation of podocalyxin (PC) and ezrin in podocytes was associated with the stability of the PC/ezrin complex.
Yuan YP; Zhao H; Peng LQ; Li ZF; Liu S; Yuan CY; Mwamunyi MJ; Pearce D; Yao LJ
Cell Death Dis; 2018 Nov; 9(11):1114. PubMed ID: 30385740
[TBL] [Abstract][Full Text] [Related]
9. SUMOylation regulates the intracellular fate of ZO-2.
Wetzel F; Mittag S; Cano-Cortina M; Wagner T; Krämer OH; Niedenthal R; Gonzalez-Mariscal L; Huber O
Cell Mol Life Sci; 2017 Jan; 74(2):373-392. PubMed ID: 27604867
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-196a/b Mitigate Renal Fibrosis by Targeting TGF-β Receptor 2.
Meng J; Li L; Zhao Y; Zhou Z; Zhang M; Li D; Zhang CY; Zen K; Liu Z
J Am Soc Nephrol; 2016 Oct; 27(10):3006-3021. PubMed ID: 26940097
[TBL] [Abstract][Full Text] [Related]
11. Beyond cell-cell adhesion: Emerging roles of the tight junction scaffold ZO-2.
Traweger A; Toepfer S; Wagner RN; Zweimueller-Mayer J; Gehwolf R; Lehner C; Tempfer H; Krizbai I; Wilhelm I; Bauer HC; Bauer H
Tissue Barriers; 2013 Apr; 1(2):e25039. PubMed ID: 24665396
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids.
Wu J; Zheng C; Fan Y; Zeng C; Chen Z; Qin W; Zhang C; Zhang W; Wang X; Zhu X; Zhang M; Zen K; Liu Z
J Am Soc Nephrol; 2014 Jan; 25(1):92-104. PubMed ID: 24029422
[TBL] [Abstract][Full Text] [Related]
13. Zona occludens-2 protects against podocyte dysfunction induced by ADR in mice.
Bautista-García P; Reyes JL; Martín D; Namorado MC; Chavez-Munguía B; Soria-Castro E; Huber O; González-Mariscal L
Am J Physiol Renal Physiol; 2013 Jan; 304(1):F77-87. PubMed ID: 23034938
[TBL] [Abstract][Full Text] [Related]
14. Effects of the differential expression of ZO-1 and ZO-2 on podocyte structure and function.
Itoh M; Nakadate K; Matsusaka T; Hunziker W; Sugimoto H
Genes Cells; 2018 Jul; 23(7):546-556. PubMed ID: 29845705
[TBL] [Abstract][Full Text] [Related]
15. AF1q Contributes to Adriamycin-Induced Podocyte Injury by Activating Wnt/β-Catenin Signaling.
Zhang H; Ren R; Du J; Sun T; Wang P; Kang P
Kidney Blood Press Res; 2017; 42(5):794-803. PubMed ID: 29069662
[TBL] [Abstract][Full Text] [Related]
16. Effects of hydrogen sulfide on high glucose-induced glomerular podocyte injury in mice.
Liu Y; Zhao H; Qiang Y; Qian G; Lu S; Chen J; Wang X; Guan Q; Liu Y; Fu Y
Int J Clin Exp Pathol; 2015; 8(6):6814-20. PubMed ID: 26261567
[TBL] [Abstract][Full Text] [Related]
17. Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury.
He W; Kang YS; Dai C; Liu Y
J Am Soc Nephrol; 2011 Jan; 22(1):90-103. PubMed ID: 21030600
[TBL] [Abstract][Full Text] [Related]
18. Wnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease.
Zhou L; Liu Y
Nat Rev Nephrol; 2015 Sep; 11(9):535-45. PubMed ID: 26055352
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
